New GPRA Launch Delayed to January 21

SAMHSA is delaying the launch of the new version of the GPRA until January 21, 2023. This means you should continue to use the version currently on the SOR website for all interview conducted through Friday, January 20. Beginning on Saturday, January 21, all interviews should be conducted using the new version. We will provide more details in January as the switch approaches. (Note: this switch was originally scheduled to occur on December 10, so if you see that date on any past materials, please ignore and plan for the January timeline instead.)

Even though the launch of the new version is delayed, we will still be holding our webinar tomorrow (November 29) from 11:00am to Noon ET to walk you through the changes to the GPRA so you can see what the new tool looks like. Please register here for the webinar if you haven’t already: https://omni-org.zoom.us/meeting/register/tZcsdeusqzwvH9TZWhLNimE133sULysJxXGg

Please reach out to our team if you have any questions (SORSupport@omni.org).

https://www.ecfr.gov/current/title-2/subtitle-A/chapter-II/part-200#200.112 Per 2 C.F.R. § 200.112-1113 The Federal awarding agency must establish conflict of interest policies for Federal awards. The non-Federal entity must disclose in writing any potential conflict of interest to the Federal awarding agency or pass-through entity in accordance with applicable Federal awarding agency policy. Failure to adhere to these statues will result in immediate termination of funding.

Virginia’s State Opioid Response (SOR) grant is awarded at the discretion of DBHDS and SAMHSA. All recipients of SOR funding supports evidence-based prevention, treatment and recovery services to address opioid and stimulant misuse and use disorders, including for cocaine and methamphetamine. The SOR grant is not intended to be utilized as a long-term or permanent funding source. All SOR proposals must include a realistic plan for financial sustainability beyond the grant period.